RAD51D and cancer: In contrast, data on cancer risk for PALB2, RAD51C, and RAD51D GPV carriers are limited and lifetime cancer risks largely depend on both family history and personal risk factors, such as age of menarche, use of oral contraceptives, and the number of children.